These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9205002)

  • 1. Characterization of functional assays of multidrug resistance P-glycoprotein transport activity.
    Bosch I; Crankshaw CL; Piwnica-Worms D; Croop JM
    Leukemia; 1997 Jul; 11(7):1131-7. PubMed ID: 9205002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
    Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
    Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.
    Márián T; Balkay L; Trón L; Krasznai ZT; Szabó-Péli J; Krasznai Z
    Eur J Pharm Sci; 2005 Apr; 24(5):495-501. PubMed ID: 15784339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.
    Boer R; Gekeler V; Ulrich WR; Zimmermann P; Ise W; Schödl A; Haas S
    Eur J Cancer; 1996 May; 32A(5):857-61. PubMed ID: 9081366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring interactions at ATP-dependent drug efflux pumps.
    Hendrikse NH
    Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
    Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of P-glycoprotein transport and inhibition in vivo.
    Barbarics E; Kronauge JF; Cohen D; Davison A; Jones AG; Croop JM
    Cancer Res; 1998 Jan; 58(2):276-82. PubMed ID: 9443405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
    Castro AF; Altenberg GA
    Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel areneisonitrile Tc complex inhibits the transport activity of MDR P-glycoprotein.
    Rao VV; Herman LW; Kronauge JF; Piwnica-Worms D
    Nucl Med Biol; 1998 Apr; 25(3):225-32. PubMed ID: 9620627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
    Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
    Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
    Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K
    Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
    Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.
    Spoelstra EC; Westerhoff HV; Dekker H; Lankelma J
    Eur J Biochem; 1992 Jul; 207(2):567-79. PubMed ID: 1353020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
    Sharom FJ; Lu P; Liu R; Yu X
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi.
    Kabasakal L; Halaĉ M; Nisli C; Oguz O; Onsel C; Civi G; Uslu I
    Clin Nucl Med; 2000 Jan; 25(1):20-3. PubMed ID: 10634525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.